Clinical Trial TitleAlzheimer's Disease Neuroimaging Initiative 3
National Clinical Trial Number:NCT02854033
Clinical Trial Protocol Description:
This study (ADNI3) looks at the relationship between clinical, cognitive (thinking and memory), imaging scans, genetic (hereditary) and biomarker (substance used as an indicator) tests over time. This will help researchers to better understand Alzheimer's disease from its earliest stages.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Be 55-90 years old
- Have an individual who knows you well, willing to take part in the study with you as your study partner.
You will be excluded from the study if any of the following criteria apply to you:
- Are unable or unwilling to complete all study activities
This is a partial list of inclusion and exclusion criteria.